Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isaac J Powell

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
American Journal of Cancer Research|November 13, 2018
The extrema of circulating miR-17 are identified as biomarkers for aggressive prostate cancerGreg Dyson, Batoul Farran, Susan Bolton, et al.
Nature Reviews. Urology|December 15, 2020
Supporting Black voices in urologyTracy M Downs, Ekene Enemchukwu, Cheryl T Lee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 22, 2013
Genes associated with prostate cancer are differentially expressed in African American and European American menIsaac J Powell, Greg Dyson, Susan Land, et al.
JNCI Cancer Spectrum|January 26, 2022
DNA Repair Pathways and Their Association With Lethal Prostate Cancer in African American and European American MenAnna Plym, Miklós Dióssy, Zoltan Szallasi, et al.
The Journal of Urology|October 24, 2002
Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109Isaac J Powell, Catherine M Tangen, Gary J Miller, et al.
Journal of National Black Nurses' Association : JNBNA|September 24, 2008
A decision aid for teaching limitations of prostate cancer screeningSally P Weinrich, Rachelle E Seger, Ganesh S Rao, et al.
The Prostate|September 4, 2008
Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic casesChristiane M Robbins, Wenndy Hernandez, Chiledum Ahaghotu, et al.
The Journal of Urology|August 28, 2012
Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346)Catherine M Tangen, Maha H A Hussain, Celestia S Higano, et al.
Urology|March 6, 2012
Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109Ryan K Berglund, Catherine M Tangen, Isaac J Powell, et al.
Urology|February 5, 2008
The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancerElisabeth I Heath, Michael W Kattan, Isaac J Powell, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
American Journal of Cancer Research|November 13, 2018
The extrema of circulating miR-17 are identified as biomarkers for aggressive prostate cancerGreg Dyson, Batoul Farran, Susan Bolton, et al.
Nature Reviews. Urology|December 15, 2020
Supporting Black voices in urologyTracy M Downs, Ekene Enemchukwu, Cheryl T Lee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 22, 2013
Genes associated with prostate cancer are differentially expressed in African American and European American menIsaac J Powell, Greg Dyson, Susan Land, et al.
JNCI Cancer Spectrum|January 26, 2022
DNA Repair Pathways and Their Association With Lethal Prostate Cancer in African American and European American MenAnna Plym, Miklós Dióssy, Zoltan Szallasi, et al.
The Journal of Urology|October 24, 2002
Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109Isaac J Powell, Catherine M Tangen, Gary J Miller, et al.
Journal of National Black Nurses' Association : JNBNA|September 24, 2008
A decision aid for teaching limitations of prostate cancer screeningSally P Weinrich, Rachelle E Seger, Ganesh S Rao, et al.
The Prostate|September 4, 2008
Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic casesChristiane M Robbins, Wenndy Hernandez, Chiledum Ahaghotu, et al.
The Journal of Urology|August 28, 2012
Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346)Catherine M Tangen, Maha H A Hussain, Celestia S Higano, et al.
Urology|March 6, 2012
Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109Ryan K Berglund, Catherine M Tangen, Isaac J Powell, et al.
Urology|February 5, 2008
The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancerElisabeth I Heath, Michael W Kattan, Isaac J Powell, et al.
Pageof 5